
Imran Ahmad Ansari
About Imran Ahmad Ansari
Data last updated:
Imran Ahmad Ansari is a Director at Orange Medipharmaceuticals Private Limited (since 2015). The companies operate in Pharma. Orange Medipharmaceuticals Private Limited reported revenue of ₹74.4 Lakh (FY 2024). Earlier, Imran Ahmad Ansari was a Designated Partner at Orange Medipharma Llp (from 2015).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Nov 2015 | 2015 | ₹74.4 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 17 Apr 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Imran Ahmad Ansari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abdullah Saleh Salmen Anooz Al Ameri | 07768053 | Orange Medipharmaceuticals Private Limited | Director |
| Humera Yaseen | 07155931 | Orange Medipharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Imran Ahmad Ansari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Imran Ahmad Ansari
Imran Ahmad Ansari currently holds 1 directorship: Orange Medipharmaceuticals Private Limited (Director, since 05 Nov 2015, revenue ₹74.4 Lakh (FY 2024)).
Imran Ahmad Ansari was first appointed on 17 Apr 2015 as Designated Partner at Orange Medipharma Llp.
Imran Ahmad Ansari held 1 earlier board appointment: Orange Medipharma Llp (Designated Partner, from 17 Apr 2015).
The current boards of Imran Ahmad Ansari's companies include Abdullah Saleh Salmen Anooz Al Ameri (Orange Medipharmaceuticals Private Limited), Humera Yaseen (Orange Medipharmaceuticals Private Limited).